Live Web Chat: Understanding Alzheimer's Disease
NEW YORK -- There is a lot of fear and confusion concerning Alzheimer's Disease. What is it exactly and how does it compare with other types of dementia? Can it be prevented or managed - and if there is no cure, why are research and early detection critical?
Experts from NewYork-Presbyterian Hospital spoke with Eyewitness News Shirleen Allicot to bring us answers, discussing the latest in Alzheimer's research and care.
Watch Segment 1:
Watch Segment 2:
Watch Segment 3:
Watch Segment 4:
Dr. Honig's clinical care activities include evaluation and treatment of memory and language dysfunction, and other cognitive and behavior changes in adults. His clinical research projects focus on Alzheimer's disease, Parkinson's disease, cerebrovascular effects on cognition, frontotemporal and corticobasal degeneration, and essential tremor, using epidemiological, laboratory and neuroimaging modalities. Dr. Honig's laboratory-based research principally concerns developing biomarkers for neurodegenerative disease, and using molecular biological tools to analyze gene expression and tissue changes in aging and human brain diseases.
He has chaired the American Academy of Neurology (AAN) Undergraduate Education Subcommittee working group in dementia and received the AAN Education Research Grant for "Evaluating the effectiveness of Continuum: Dementia as a teaching tool for medical students" published in Neurology. He is the author of numerous publications and has presented his research in neurology and medical education at scientific meetings nationally and internationally, and was awarded the 2009 AAN A.B. Baker Teacher Recognition Award.
